These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1952571)

  • 41. Effect of a leukotriene receptor antagonist on LTC4 vasoconstriction in rat stomach.
    Yonei Y; Guth PH
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G147-54. PubMed ID: 2372059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro airway and tissue response to antigen in sensitized rats. Role of serotonin and leukotriene D4.
    Nagase T; Fukuchi Y; Dallaire MJ; Martin JG; Ludwig MS
    Am J Respir Crit Care Med; 1995 Jul; 152(1):81-6. PubMed ID: 7599867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of leukotriene D4 in the early and late pulmonary responses of rats to allergen challenge.
    Sapienza S; Eidelman DH; Renzi PM; Martin JG
    Am Rev Respir Dis; 1990 Aug; 142(2):353-8. PubMed ID: 2382899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078.
    Yamamoto H; Nagata M; Kuramitsu K; Tabe K; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
    Am J Respir Crit Care Med; 1994 Jul; 150(1):254-7. PubMed ID: 8025759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of granulocytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor.
    Hazel BA; Kalf GF
    Recept Signal Transduct; 1996; 6(1):1-12. PubMed ID: 8933618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of calcitonin gene-related peptide (CGRP) in hyperpnea-induced constriction in guinea pigs.
    Nagase T; Ohga E; Katayama H; Sudo E; Aoki T; Matsuse T; Ouchi Y; Fukuchi Y
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1551-6. PubMed ID: 8912779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Wong WS; Zhu H; Liao W
    Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formation of PGD2 after allergen inhalation in atopic asthmatics.
    Sladek K; Sheller JR; FitzGerald GA; Morrow JD; Roberts LJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():433-6. PubMed ID: 1847781
    [No Abstract]   [Full Text] [Related]  

  • 49. Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist.
    Depré M; Margolskee DJ; Van Hecken A; Hsieh JS; Buntinx A; De Schepper PJ; Rogers JD
    Eur J Clin Pharmacol; 1992; 43(4):431-3. PubMed ID: 1451726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man.
    Evans JM; Barnes NC; Zakrzewski JT; Sciberras DG; Stahl EG; Piper PJ; Costello JF
    Br J Clin Pharmacol; 1989 Aug; 28(2):125-35. PubMed ID: 2775617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204,219.
    Dahlén SE; Dahlén B; Eliasson E; Johansson H; Björck T; Kumlin M; Boo K; Whitney J; Binks S; King B
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():461-4. PubMed ID: 1847783
    [No Abstract]   [Full Text] [Related]  

  • 53. Possible role of leukotrienes in hypoxic contraction of canine isolated basilar artery.
    Gu M; Elliott DA; Ong BY; Bose D
    Br J Pharmacol; 1991 Jul; 103(3):1629-32. PubMed ID: 1933128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis.
    Gyllfors P; Kumlin M; Dahlén SE; Gaber F; Ehrs PO; Dahlén B
    Thorax; 2005 Nov; 60(11):902-8. PubMed ID: 16055619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early efficacy data with a newer generation of LTD4 antagonists in antiasthma trials: early promise for a single mediator antagonist.
    Cheng JB
    Pulm Pharmacol; 1992 Jun; 5(2):77-80. PubMed ID: 1611235
    [No Abstract]   [Full Text] [Related]  

  • 56. High-performance liquid chromatographic method for the determination of a novel leukotriene D4 antagonist (MK-0571) in biological specimens.
    Berna RA; Zacchei AG
    J Chromatogr; 1991 Feb; 563(2):458-65. PubMed ID: 2056010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukotriene receptor antagonists versus inhaled steroids in asthma.
    Richardson CR
    J Fam Pract; 1999 Jul; 48(7):495-6. PubMed ID: 10428241
    [No Abstract]   [Full Text] [Related]  

  • 58. Physiological disposition of aerosolized MK-679 in rats.
    Tocco DJ; deluna FA; Vadas E; Lin JH
    Drug Metab Dispos; 1992; 20(3):428-31. PubMed ID: 1355719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia.
    Porreca E; Di Febbo C; Di Sciullo A; Angelucci D; Nasuti M; Vitullo P; Reale M; Conti P; Cuccurullo F; Poggi A
    Thromb Haemost; 1996 Jul; 76(1):99-104. PubMed ID: 8819260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.